HTATIP2 and cancer: The initial search strategy identified 135 studies; 40 duplicated studies were removed, 79 studies were excluded because they did not refer to the relationship between TIP30 and patients with cancers, and 2 studies were excluded because they lacked relevant outcome variables and clinicopathological features associating TIP30 and human cancer (Fig 1).